Antral follicle count provides additive information to hormone measures for determining ovarian function in breast cancer survivors

被引：8
|
作者：
Su, H. Irene [1 ]
Chung, Karine [2 ]
Sammel, Mary D. [3 ]
Gracia, Clarisa R. [3 ,4 ]
DeMichele, Angela [3 ,5 ]
机构：
[1] Univ Calif San Diego, Moores Canc Ctr, Dept 0901, Div Reprod Endocrinol & Infertil, La Jolla, CA 92093 USA
[2] Univ So Calif, Div Reprod Endocrinol & Infertil, Los Angeles, CA USA
[3] Univ Penn, Sch Med, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA
[4] Univ Penn, Sch Med, Div Reprod Endocrinol & Infertil, Philadelphia, PA 19104 USA
[5] Univ Penn, Sch Med, Rowan Breast Ctr, Abramson Canc Ctr, Philadelphia, PA 19104 USA
来源：
FERTILITY AND STERILITY | 2011年 / 95卷 / 05期
关键词：
Breast cancer; antral follicle count; ovarian reserve; AMH; FSH; PREMENOPAUSAL WOMEN; YOUNG-WOMEN; RESERVE; CHEMOTHERAPY;
D O I：
10.1016/j.fertnstert.2010.12.005
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
In breast cancer survivors, antral follicle count appears to provide data on ovarian function that are independent of antimullerian hormone, FSH, and inhibin B. Therefore, ultrasound appears to be a tool that may not only corroborate, but also add to the accuracy of hormone measures for determining ovarian function in breast cancer survivors. (Fertil Steril (R) 2011;95:1857-9. (C)2011 by American Society for Reproductive Medicine.)
引用
收藏
页码：1857 / 1859
页数：3
相关论文
共 50 条
  • [41] Comparison of anti-Müllerian hormone and antral follicle count in the prediction of ovarian response: a systematic review and meta-analysis
    Yang Liu
    Zhengmei Pan
    Yanzhi Wu
    Jiamei Song
    Jingsi Chen
    Journal of Ovarian Research, 16
  • [42] Prediction of high ovarian response to controlled ovarian hyperstimulation: anti-Mullerian hormone versus small antral follicle count (2-6 mm)
    Aflatoonian, Abbas
    Oskouian, Homa
    Ahmadi, Shahnaz
    Oskouian, Leila
    JOURNAL OF ASSISTED REPRODUCTION AND GENETICS, 2009, 26 (06) : 319 - 325
  • [43] Can delivery mode influence future ovarian reserve? Anti-Mullerian hormone levels and antral follicle count following cesarean section: a prospective cohort study
    Moini, Ashraf
    Pirjani, Reihaneh
    Rabiei, Maryam
    Nurzadeh, Maryam
    Sepidarkish, Mahdi
    Hosseini, Reihaneh
    Hosseini, Ladan
    JOURNAL OF OVARIAN RESEARCH, 2019, 12 (01)
  • [44] Correlation of Anti-Mullerian Hormone Level and Antral Follicle Count with Oocyte Number in A Fixed-Dose Controlled Ovarian Hyperstimulation of Patients of In Vitro Fertilization Program
    Permadi, Wiryawan
    Ferdian, Mohammad Wahyu
    Tjahyadi, Dian
    Iswari, Wulan Ardhana
    Djuwantono, Tono
    INTERNATIONAL JOURNAL OF FERTILITY & STERILITY, 2021, 15 (01) : 40 - 43
  • [45] Can delivery mode influence future ovarian reserve? Anti-Mullerian hormone levels and antral follicle count following cesarean section: a prospective cohort study
    Ashraf Moini
    Reihaneh Pirjani
    Maryam Rabiei
    Maryam Nurzadeh
    Mahdi Sepidarkish
    Reihaneh Hosseini
    Ladan Hosseini
    Journal of Ovarian Research, 12
  • [46] Is assessment of anti-mullerian hormone and/or antral follicle count useful in the prediction of ovarian response in expected normal responders treated with a fixed dose of recombinant FSH and GnRH antagonists? A prospective observational study
    Ganidou, Maria A.
    Kolibianakis, Efstratios M.
    Venetis, Christos A.
    Gerou, Spiros
    Makedos, Georgios A.
    Klearchou, Nikolaos
    Tarlatzis, Basil C.
    GYNECOLOGICAL ENDOCRINOLOGY, 2014, 30 (11) : 817 - 821
  • [47] Prediction of ovarian function recovery in young breast cancer patients after protection with gonadotropin-releasing hormone agonist during chemotherapy
    Lee, Dong-Yun
    Park, Yeon Hee
    Lee, Jeong Eon
    Choi, DooSeok
    BREAST CANCER RESEARCH AND TREATMENT, 2018, 171 (03) : 649 - 656
  • [48] Anti-Mullerian hormone as an age-related predictor of the antral follicle count and the response to exogenous FSH ovarian reserve test in sheep
    Berlinguer, F.
    Torres-Rovira, L.
    Spezzigu, A.
    Leoni, G.
    Succu, S.
    Gallus, M.
    Naitana, S.
    Gonzalez-Bulnes, A.
    REPRODUCTION IN DOMESTIC ANIMALS, 2012, 47 : 493 - 493
  • [49] Oncologic Safety of Gonadotropin-Releasing Hormone Agonist for Ovarian Function Protection During Breast Cancer Chemotherapy
    Kim, Hee Jeong
    Lee, Moo Hyun
    Lee, Jeong Eon
    Park, Seho
    Lee, Eun Sook
    Kang, Yong Joon
    Shin, Hae Na
    Kim, Seung Il
    Lee, Jun Ho
    Im, Seock Ah
    Ahn, Sei Hyun
    Lee, Keun Seok
    Sohn, Joohyuk
    Kim, Seonok
    Nam, Seok Jin
    Han, Wonshik
    CLINICAL BREAST CANCER, 2018, 18 (05) : E1165 - E1172
  • [50] Incomplete ovarian function suppression in premenopausal breast cancer patients treated with gonadotropin-releasing hormone agonists
    Lin, Jinna
    Zheng, Shuqi
    Liu, Qiang
    CANCER TREATMENT REVIEWS, 2025, 133
12345